H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report) shares passed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $22.00 and traded as low as $22.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares.
H. Lundbeck A/S Stock Performance
The stock has a market cap of $21.91 billion, a PE ratio of 25.00 and a beta of 0.68. The company has a fifty day moving average price of $22.00 and a 200 day moving average price of $22.00. The company has a quick ratio of 0.71, a current ratio of 1.15 and a debt-to-equity ratio of 0.32.
About H. Lundbeck A/S
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
Read More
- Five stocks we like better than H. Lundbeck A/S
- Canadian Penny Stocks: Can They Make You Rich?
- Comprehensive Analysis of PayPal Stock
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Intuitive Surgical Stock Can Trend Much Higher This Year
- EV Stocks and How to Profit from Them
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
